Patent holdings for IPC class A61K 31/427

Total number of patents in this class: 3990

10-year publication summary

236
270
276
266
307
258
214
264
245
93
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Merck Sharp & Dohme LLC
3729
62
Novartis AG
10327
59
F. Hoffmann-La Roche AG
7837
43
Takeda Pharmaceutical Company Limited
2718
41
The Regents of the University of California
20574
40
Dana-Farber Cancer Institute, Inc.
2648
36
Gilead Sciences, Inc.
2189
36
The United States of America, as represented by the Secretary, Department of Health and Human Services
2973
35
Boehringer Ingelheim International GmbH
4509
33
Bristol-myers Squibb Company
4811
32
Janssen Pharmaceutica N.V.
3231
32
Daiichi Sankyo Company, Limited
1886
29
Shionogi & Co., Ltd.
863
28
Abbvie Inc.
1842
27
Hoffmann-La Roche Inc.
3699
26
Genentech, Inc.
4076
26
Pfizer Inc.
3367
25
Centre National de La Recherche Scientifique
10886
20
Bayer AG
3430
20
The Trustees of the University of Pennsylvania
4406
20
Other owners 3320